ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1453–1464 of 2020 project topics
Congenital Erythropoietic Porphyria UROS Analysis
Identifying UROS pathogenic variants causing CEP and correlating genotype with clinical severity for predicting need for hematopoietic stem cell transplant.
Genetic Basis of Porphyrias Click to view more details →
Porphyria Cutanea Tarda HFE and UROD Testing
Investigating HFE hemochromatosis variants and UROD mutations as risk factors for PCT development for molecular risk assessment.
Genetic Basis of Porphyrias Click to view more details →
Variegate Porphyria PROTOX2 Mutation Detection SaaS
A cloud-based diagnostic platform that identifies PROTOX2 gene mutations in variegate porphyria patients through automated sequencing analysis and variant interpretation. This service generates recurring subscription revenue from clinical laboratories and enables rapid patient stratification for targeted therapeutic interventions.
Genetic Basis of Porphyrias Click to view more details →
X-Linked Protoporphyria ALAS2 Comprehensive Genotyping Tool
An enterprise genotyping solution that provides complete ALAS2 gene analysis for X-linked protoporphyria diagnosis with phenotype-genotype correlation reports. The tool monetizes through laboratory licensing fees and provides pharmaceutical companies with patient population data for clinical trial recruitment.
Genetic Basis of Porphyrias Click to view more details →
Porphyria Genetic Risk Stratification AI Platform
An artificial intelligence-powered platform that analyzes multi-gene panels across all porphyria types to predict disease severity and clinical outcomes. This generates revenue through tiered licensing models for healthcare systems and supports personalized medicine initiatives that improve patient management costs.
Genetic Basis of Porphyrias Click to view more details →
Dual ALAD and PBGD Acute Porphyria Rapid Panel Kit
A high-throughput molecular diagnostic kit targeting ALAD and PBGD genes for rapid identification of acute porphyria subtypes in emergency settings. This consumable-based product delivers recurring revenue through kit sales to clinical laboratories while reducing emergency department diagnostic turnaround time.
Genetic Basis of Porphyrias Click to view more details →
Porphyria Carrier Screening Database and Counseling Platform
A digital health platform combining carrier screening databases with genetic counseling tools for population-based porphyria risk identification and management. The platform generates revenue through licensing agreements with reproductive health clinics and ancestry testing companies seeking expanded genetic disorder detection.
Genetic Basis of Porphyrias Click to view more details →
Hepatic Porphyria Pharmacogenomics Integration Dashboard
A clinical dashboard integrating porphyria genetic profiles with drug-drug interaction databases to optimize medication selection for affected patients. This software-as-a-service solution monetizes through healthcare provider subscriptions and reduces adverse event liability for pharmaceutical companies managing porphyria patient populations.
Genetic Basis of Porphyrias Click to view more details →
Bernard-Soulier Syndrome GP1BA Gene Testing
Characterizing GP1BA, GP1BB, and GP9 variants causing Bernard-Soulier syndrome for molecular diagnosis in patients with macrothrombocytopenia.
Genetic Basis of Bleeding Diathesis Click to view more details →
Glanzmann Thrombasthenia ITGA2B ITGB3 Analysis
Developing ITGA2B and ITGB3 molecular testing for Glanzmann thrombasthenia diagnosis and correlating genotype with residual integrin expression.
Genetic Basis of Bleeding Diathesis Click to view more details →
Storage Pool Disease Gene Identification
Using WES for identifying causative variants in dense and alpha granule deficiency syndromes including HPS, CHS, and AP3B1 mutations.
Genetic Basis of Bleeding Diathesis Click to view more details →
Gray Platelet Syndrome NBEAL2 Testing
Characterizing NBEAL2 pathogenic variants causing gray platelet syndrome for molecular diagnosis in patients with macrothrombocytopenia and myelofibrosis.
Genetic Basis of Bleeding Diathesis Click to view more details →